| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |